These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 38051386)
1. [Management of cardiomyopathies : New ESC guidelines 2023]. Pavo N; Hengstenberg C Herz; 2024 Feb; 49(1):22-32. PubMed ID: 38051386 [TBL] [Abstract][Full Text] [Related]
2. The new European Society of Cardiology guideline for the management of cardiomyopathies: key messages for cardiac electrophysiologists. Korthals D; Eckardt L Herzschrittmacherther Elektrophysiol; 2023 Dec; 34(4):311-323. PubMed ID: 37973628 [TBL] [Abstract][Full Text] [Related]
3. [The 2014 ESC guidelines on the diagnosis and management of hypertrophic cardiomyopathy : what is new?]. Maisch B; Mahrholdt H; Herz; 2014 Dec; 39(8):919-30. PubMed ID: 25410471 [TBL] [Abstract][Full Text] [Related]
4. [Classification of cardiomyopathies and indication for endomyocardial biopsy revisited]. Pankuweit S; Richter A; Ruppert V; Maisch B Herz; 2009 Feb; 34(1):55-62. PubMed ID: 19214409 [TBL] [Abstract][Full Text] [Related]
5. [Cardiomyopathies: a practical approach to the assessment and management of patients and their families]. Hiestand R; Gruner C Ther Umsch; 2024 Apr; 81(2):60-66. PubMed ID: 38780212 [TBL] [Abstract][Full Text] [Related]
6. Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC). de Boer RA; Heymans S; Backs J; Carrier L; Coats AJS; Dimmeler S; Eschenhagen T; Filippatos G; Gepstein L; Hulot JS; Knöll R; Kupatt C; Linke WA; Seidman CE; Tocchetti CG; van der Velden J; Walsh R; Seferovic PM; Thum T Eur J Heart Fail; 2022 Mar; 24(3):406-420. PubMed ID: 34969177 [TBL] [Abstract][Full Text] [Related]
7. [New guidelines on the diagnostic and therapeutic management of hypertrophic cardiomyopathy]. Lancellotti P; Masson A; Damas F; de Marneffe N Rev Med Liege; 2023 Nov; 78(11):619-625. PubMed ID: 37955291 [TBL] [Abstract][Full Text] [Related]
8. Accuracy of the ECG for differential diagnosis between hypertrophic cardiomyopathy and athlete's heart: comparison between the European Society of Cardiology (2010) and International (2017) criteria. Zorzi A; Calore C; Vio R; Pelliccia A; Corrado D Br J Sports Med; 2018 May; 52(10):667-673. PubMed ID: 28701362 [TBL] [Abstract][Full Text] [Related]
9. Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology. Seferović PM; Polovina M; Bauersachs J; Arad M; Ben Gal T; Lund LH; Felix SB; Arbustini E; Caforio ALP; Farmakis D; Filippatos GS; Gialafos E; Kanjuh V; Krljanac G; Limongelli G; Linhart A; Lyon AR; Maksimović R; Miličić D; Milinković I; Noutsias M; Oto A; Oto Ö; Pavlović SU; Piepoli MF; Ristić AD; Rosano GMC; Seggewiss H; Ašanin M; Seferović JP; Ruschitzka F; Čelutkiene J; Jaarsma T; Mueller C; Moura B; Hill L; Volterrani M; Lopatin Y; Metra M; Backs J; Mullens W; Chioncel O; de Boer RA; Anker S; Rapezzi C; Coats AJS; Tschöpe C Eur J Heart Fail; 2019 May; 21(5):553-576. PubMed ID: 30989768 [TBL] [Abstract][Full Text] [Related]
10. The Cardiomyopathy Registry of the EURObservational Research Programme of the European Society of Cardiology: baseline data and contemporary management of adult patients with cardiomyopathies. Charron P; Elliott PM; Gimeno JR; Caforio ALP; Kaski JP; Tavazzi L; Tendera M; Maupain C; Laroche C; Rubis P; Jurcut R; Calò L; Heliö TM; Sinagra G; Zdravkovic M; Kavoliuniene A; Felix SB; Grzybowski J; Losi MA; Asselbergs FW; García-Pinilla JM; Salazar-Mendiguchia J; Mizia-Stec K; Maggioni AP; Eur Heart J; 2018 May; 39(20):1784-1793. PubMed ID: 29378019 [TBL] [Abstract][Full Text] [Related]
11. [Classification of cardiomyopathy]. Asakura M; Kitakaze M Masui; 2014 Jan; 63(1):5-15. PubMed ID: 24558926 [TBL] [Abstract][Full Text] [Related]
12. Update on hypertrophic cardiomyopathy and a guide to the guidelines. Sen-Chowdhry S; Jacoby D; Moon JC; McKenna WJ Nat Rev Cardiol; 2016 Nov; 13(11):651-675. PubMed ID: 27681577 [TBL] [Abstract][Full Text] [Related]
13. Cardiomyopathies in the Clinical Practice - an Overview. Schulz LP; Vischer AS Praxis (Bern 1994); 2022 Aug; 111(11):623-631. PubMed ID: 35975415 [No Abstract] [Full Text] [Related]
14. Cardiovascular magnetic resonance in the guidelines of the European Society of Cardiology: a comprehensive summary and update. von Knobelsdorff-Brenkenhoff F; Schulz-Menger J J Cardiovasc Magn Reson; 2023 Jul; 25(1):42. PubMed ID: 37482604 [TBL] [Abstract][Full Text] [Related]
15. Validation of the 2014 European Society of Cardiology guidelines risk prediction model for the primary prevention of sudden cardiac death in hypertrophic cardiomyopathy. Vriesendorp PA; Schinkel AF; Liebregts M; Theuns DA; van Cleemput J; Ten Cate FJ; Willems R; Michels M Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):829-35. PubMed ID: 25922410 [TBL] [Abstract][Full Text] [Related]
16. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology. Maron BJ; Udelson JE; Bonow RO; Nishimura RA; Ackerman MJ; Estes NA; Cooper LT; Link MS; Maron MS; Circulation; 2015 Dec; 132(22):e273-80. PubMed ID: 26621644 [No Abstract] [Full Text] [Related]
17. Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology (EAPC). Pelliccia A; Solberg EE; Papadakis M; Adami PE; Biffi A; Caselli S; La Gerche A; Niebauer J; Pressler A; Schmied CM; Serratosa L; Halle M; Van Buuren F; Borjesson M; Carrè F; Panhuyzen-Goedkoop NM; Heidbuchel H; Olivotto I; Corrado D; Sinagra G; Sharma S Eur Heart J; 2019 Jan; 40(1):19-33. PubMed ID: 30561613 [TBL] [Abstract][Full Text] [Related]
18. Predicting therapies in Japanese hypertrophic cardiomyopathy patients with an implantable cardioverter-defibrillator using the 2014 European Society of Cardiology guidelines. Nakano M; Kondo Y; Nakano M; Kajiyama T; Miyazawa K; Hayashi T; Ito R; Takahira H; Kobayashi Y Heart Vessels; 2021 Jan; 36(1):99-104. PubMed ID: 32666207 [TBL] [Abstract][Full Text] [Related]
19. A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy. O'Mahony C; Tome-Esteban M; Lambiase PD; Pantazis A; Dickie S; McKenna WJ; Elliott PM Heart; 2013 Apr; 99(8):534-41. PubMed ID: 23339826 [TBL] [Abstract][Full Text] [Related]
20. [Interpretation of the 2023 European Society of Cardiology (ESC) Guidelines for the management of cardiomyopathies]. Zheng XH; Jiang M; Li XL Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Nov; 51(11):1199-1204. PubMed ID: 37963758 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]